Liquid chromatography
Published over 5 years ago. See the latest and most current information on Liquid chromatography.
The identification in recent years of the strong connection between neuroactive peptides and migraine has greatly incentivized further research and development of small protein molecules for treatment and prevention of this debilitating disorder. Correspondingly the demand for more efficient methods of purifying peptides has increased, especially in reversed phase chromatography, which has been shown to be very well suited to the task with excellent recovery and resolution. Reverse phase method development for this application, however, requires careful consideration of key parameters such as sample loading and stationary phase particle size.
Our featured guest speaker on this topic is Dr. Christopher R. Coxon, Institute of Chemical Sciences, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh, UK. Dr. Coxon is also one of the co-authors of our Chromatography Application Note AN115: “Reversed Phase Flash Chromatography Purification of Peptide-Peptoid Hybrids.”
The moderator for this event is Josh Lovell, Applications Specialist at Teledyne ISCO, responsible for helping customers solve challenging problems in analytical, flash, and preparatory chromatography applications.
In this webinar Dr. Coxon will discuss the latest treatments for migraine and the evidence showing peptides could be the best way forward. He will also describe his team’s work in discovering new treatments and how the latest peptide-related research technologies are being employed.
From this 45-minute presentation plus interactive Q&A session, attendees will gain stronger insight into the role of small protein molecules, how to better purify them with reverse phase flash chromatography methods, and how to quickly solve the most common method development problems.
This webinar will be offered three times on Tuesday, April 6. To register, click on the time you would like to attend.
Product directory
